相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia
Alessandra Ferrajoli et al.
BLOOD (2008)
Lenalidomide for the treatment of B-cell malignancies
Asher A. Chanan-Khan et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia
Leslie A. Andritsos et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Community-based phase II trial of PCR for CLL/SLL patients
Neil E. Kay et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2007)
Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pre-treated patients with chronic lymphocytic leukemia
Luca Laurenti et al.
LEUKEMIA RESEARCH (2007)
Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: Results of a phase II study
Asher Chanan-Khan et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Immunomodulating drugs for chronic lymphocytic leukaemia
Asher Chanan-Khan et al.
LANCET ONCOLOGY (2006)
Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL)
A Chanan-Khan et al.
BLOOD (2005)
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia
MJ Keating et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells
O Bairey et al.
LEUKEMIA RESEARCH (2004)
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)
JC Byrd et al.
BLOOD (2003)
B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules
NE Kay et al.
LEUKEMIA (2002)
Angiogenesis in B-cell chronic lymphocytic leukemia: Methods of study, clinical significance and prognostic implications
S Molica
LEUKEMIA & LYMPHOMA (2001)
Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia
AR Kini et al.
LEUKEMIA (2000)
分享论文
